FDA Approves Regorafenib for Metastatic CRC

  The FDA today approved the use of the drug regorafenib (brand name Stivarga) for patients whose metastatic colorectal cancer has progressed despite all currently approved treatment regimens. This is the second new drug approved by the FDA recently after a drought of 5 years in approving new treatments for metastatic colorectal cancer (mCRC). Regorafenib was placed…  Read More

To fast or not to fast

TO EAT OR NOT TO EAT…DURING CHEMOTHERAPY To humbly paraphrase Shakespeare, the question is “whether ‘tis better to…ban sugar from your diet, or bulk up on high-protein meals…” The internet is full of raging debates, fervid testimonials and opinions about what you should or shouldn’t eat when you’re being treated for cancer.  One of the most…  Read More

Watch our Webinar on Drug Shortages

On Wednesday night, Dr. Lindsey Poppe, the Pharmacy Clinical Manager for Oncology for the University of North Carolina hospital system talked about the alternatives and options that patients have when directly faced with the current chemo drug shortage. You can watch a recording of the webinar on our website, along with all of our past patient webinars.…  Read More

Leading GI Cancer Researcher Updates Patients

Last night, Dr. Edith Mitchell of Thomas Jefferson University Kimmel Cancer Center in Philadelphia, PA, updated colorectal cancer patients on the latest research and treatment news in an online webinar. Dr. Mitchell highlighted the most important news for colon and rectal cancer patients to come from the 2011 Gastrointestinal Cancers Symposium held in San Francisco last…  Read More

How Real is Chemobrain?

Very real. Brain MRI’s before and chemotherapy found changes in brains of women being treated for breast cancer. Women who had breast cancer surgery but didn’t have chemo had similar changes, but they were less severe. Brains of healthy women remained stable. Changes were in gray matter in areas of the brain involving memory and the…  Read More

Avastin Helps Patients Maintain Chemotherapy Effectiveness

It doesn’t hurt to stop XELOX chemotherapy combined with Avastin after six treatments and continue with Avastin alone until colorectal cancer gets worse, according to a study reported at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago. Many patients have to stop oxaliplatin chemotherapy with before getting its maximum effectiveness because…  Read More